HSBC Holdings
CLB icon

HSBC Holdings’s Core Laboratories CLB Stock Holding History

HSBC Holdings’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-9,529
Closed -$1.09M – 1960
2015
Q2 		$1.09M Buy
+9,529
New +$1.16M ﹤0.01% 1223

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

HSBC Holdings's CLB Position: Q2 2026 in Review

HSBC Holdings opened a new position in Core Laboratories (CLB) in Q2 2026: 26,077 shares worth $288K. The stake represents ﹤0.01% of the portfolio and ranks #2535 among its holdings. This is a return to the name: HSBC Holdings previously reported a position in CLB as recently as Q1 2024.

HSBC Holdings first reported a position in CLB in Q2 2013 and has held it in 29 quarters since. The position peaked at $1.07M in Q3 2017. 186 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

  • HSBC Holdings held 26,077 shares of Core Laboratories worth $288K as of Q2 2026.
  • Core Laboratories was a new HSBC Holdings position in Q2 2026.
  • Core Laboratories made up ﹤0.01% of HSBC Holdings's portfolio in Q2 2026, its #2535 holding.
  • HSBC Holdings first reported a position in Core Laboratories in Q2 2013 and has held it in 29 quarters since.
  • HSBC Holdings's Core Laboratories position peaked at $1.07M in Q3 2017.
  • 186 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.